Protalix BioTherapeutics, Inc. (PLX)
NYSE: PLX · CIK 0001006281 · United States
Every official Protalix BioTherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PLX filings
Protalix BioTherapeutics, Inc. documents
- Protalix BioTherapeutics, Inc. 10-K 2026PLX 10-K 2026: annual report for fiscal 2026
- Protalix BioTherapeutics, Inc. 10-K 2025PLX 10-K 2025: annual report for fiscal 2025
- Protalix BioTherapeutics, Inc. 10-K 2024PLX 10-K 2024: annual report for fiscal 2024
- Protalix BioTherapeutics, Inc. 10-K 2023PLX 10-K 2023: annual report for fiscal 2023
- Protalix BioTherapeutics, Inc. 10-K 2022PLX 10-K 2022: annual report for fiscal 2022
- Protalix BioTherapeutics, Inc. 10-Q 2026PLX 10-Q 2026: quarterly report for fiscal 2026
- Protalix BioTherapeutics, Inc. 10-Q 2025PLX 10-Q 2025: quarterly report for fiscal 2025
- Protalix BioTherapeutics, Inc. 10-Q 2024PLX 10-Q 2024: quarterly report for fiscal 2024
- Protalix BioTherapeutics, Inc. 10-Q 2023PLX 10-Q 2023: quarterly report for fiscal 2023
- Protalix BioTherapeutics, Inc. 10-Q 2022PLX 10-Q 2022: quarterly report for fiscal 2022
- Protalix BioTherapeutics, Inc. 8-K 2026PLX 8-K 2026: current report for fiscal 2026
- Protalix BioTherapeutics, Inc. 8-K 2025PLX 8-K 2025: current report for fiscal 2025
- Protalix BioTherapeutics, Inc. 8-K 2024PLX 8-K 2024: current report for fiscal 2024
- Protalix BioTherapeutics, Inc. 8-K 2023PLX 8-K 2023: current report for fiscal 2023
- Protalix BioTherapeutics, Inc. 8-K 2022PLX 8-K 2022: current report for fiscal 2022
- Protalix BioTherapeutics, Inc. DEF 14A 2026PLX DEF 14A 2026: proxy statement for fiscal 2026
- Protalix BioTherapeutics, Inc. DEF 14A 2025PLX DEF 14A 2025: proxy statement for fiscal 2025
- Protalix BioTherapeutics, Inc. DEF 14A 2024PLX DEF 14A 2024: proxy statement for fiscal 2024
- Protalix BioTherapeutics, Inc. DEF 14A 2023PLX DEF 14A 2023: proxy statement for fiscal 2023
- Protalix BioTherapeutics, Inc. DEF 14A 2022PLX DEF 14A 2022: proxy statement for fiscal 2022
- Protalix BioTherapeutics, Inc. Form 4 2026PLX Form 4 2026: insider trading filing for fiscal 2026
- Protalix BioTherapeutics, Inc. Form 4 2025PLX Form 4 2025: insider trading filing for fiscal 2025
- Protalix BioTherapeutics, Inc. Form 4 2024PLX Form 4 2024: insider trading filing for fiscal 2024
- Protalix BioTherapeutics, Inc. Form 4 2023PLX Form 4 2023: insider trading filing for fiscal 2023
- Protalix BioTherapeutics, Inc. Form 4 2022PLX Form 4 2022: insider trading filing for fiscal 2022
- Protalix BioTherapeutics, Inc. S-1 2026PLX S-1 2026: registration statement for fiscal 2026
- Protalix BioTherapeutics, Inc. S-1 2025PLX S-1 2025: registration statement for fiscal 2025
- Protalix BioTherapeutics, Inc. S-1 2024PLX S-1 2024: registration statement for fiscal 2024
- Protalix BioTherapeutics, Inc. S-1 2023PLX S-1 2023: registration statement for fiscal 2023
- Protalix BioTherapeutics, Inc. S-1 2022PLX S-1 2022: registration statement for fiscal 2022
- Protalix BioTherapeutics, Inc. 13F 2026PLX 13F 2026: institutional holdings for fiscal 2026
- Protalix BioTherapeutics, Inc. 13F 2025PLX 13F 2025: institutional holdings for fiscal 2025
- Protalix BioTherapeutics, Inc. 13F 2024PLX 13F 2024: institutional holdings for fiscal 2024
- Protalix BioTherapeutics, Inc. 13F 2023PLX 13F 2023: institutional holdings for fiscal 2023
- Protalix BioTherapeutics, Inc. 13F 2022PLX 13F 2022: institutional holdings for fiscal 2022
More companies